A review of immunofluorescent patterns associated with antineutrophil cytoplasmic antibodies (ANCA) and their differentiation from other antibodies

被引:52
作者
Savige, JA
Paspaliaris, B
Silvestrini, R
Davies, D
Nikoloutsopoulos, T
Sturgess, A
Neil, J
Pollock, W
Dunster, K
Hendle, M
机构
[1] Univ Melbourne, Austin & Repatriat Med Ctr, Dept Med, Heidelberg, Vic 3084, Australia
[2] St Vincents Hosp, Dept Biochem, Fitzroy, Vic 3065, Australia
[3] Westmead Hosp, Dept Immunopathol, Westmead, NSW 2145, Australia
[4] SW Area Pathol Serv, Liverpool, NSW, Australia
[5] Flinders Med Ctr, SouthPath, Bedford Pk, SA, Australia
[6] St George Hosp, Dept Rheumatol, Kogarah, NSW 2217, Australia
[7] Univ Queensland, Royal Brisbane Hosp, Dept Immunol, Herston, Qld, Australia
[8] Gribbles Pathol, Immunol Lab, S Yarra, Vic, Australia
[9] Alfred Hosp, Dept Immunol, Prahran, Vic 3181, Australia
[10] Queensland Med Labs, Immunol Lab, W End, Qld, Australia
关键词
antineutrophil cytoplasmic antibodies; antigens; autoantibodies; vasculitis;
D O I
10.1136/jcp.51.8.568
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Aim-To describe the neutrophil fluorescent patterns produced by antineutrophil cytoplasmic antibodies (ANCA) with different antigen specificities, and by other auto- and alloantibodies. Background-Most sera from patients with active generalised Wegener's granulomatosis result in diffusely granular cytoplasmic neutrophil fluorescence with internuclear accentuation (cANCA) and proteinase 3 (PR3) specificity. About 80% of the sera from patients with microscopic polyangiitis result in perinuclear neutrophil fluorescence with nuclear extension (pANCA) and myeloperoxidase (MPO) specificity, or a cANCA pattern with PR3 specificity. However, many different neutrophil fluorescence patterns are noted on testing for ANCA in routine immunodiagnostic laboratories. Methods-Sera sent for ANCA testing, or containing a variety of auto- and alloantibodies, were studied. They were examined by indirect immunofluorescence according to the recommendations of the first international ANCA workshop, and for PR3 and MPO specificity in commercial and in-house enzyme linked immunosorbent assays (ELISA). Results-Sera with typical cANCA accounted for only half of all neutrophil cytoplasmic fluorescence. Other sera had "flatter" fluorescence without internuclear accentuation, and the corresponding antigens included MPO and bactericidal/ permeability increasing protein (BPI), but were usually unknown. Peripheral nuclear fluorescence without nuclear extension occurred typically when the antigens were BPI, lactoferrin, lysozyme, elastase, or cathepsin G. Most types of ANA were evident on ethanol fixed neutrophil nuclei. AntidsDNA, antiRo, and antilamin antibodies resembled pANCA. Antimicrobial and antiribosomal antibodies produced cytoplasmic fluorescence, and antiGolgi antibodies, a pANCA. Sera from patients with anti-smooth muscle antibodies were associated with cytoplasmic fluorescence. There was no neutrophil fluorescence with anti-skeletal muscle and anti-heart muscle antibodies, anti-liver/kidney microsomal, antithyroid microsomal, or antiadrenal antibodies. Alloantibodies such as antiNB1 typically resulted in cytoplasmic fluorescence of only a subpopulation of the neutrophils. Conclusions-The ability to distinguish between different neutrophil fluorescence patterns, and the patterns seen with other auto- and alloantibodies is helpful diagnostically. However, the demonstration of MPO or PR3 specificity by ELISA will indicate that the neutrophil fluorescence is probably clinically significant, and that the diagnosis is likely to be Wegener's granulomatosis or microscopic polyangiitis.
引用
收藏
页码:568 / 575
页数:8
相关论文
共 38 条
[1]   REACTIVITY OF ANTI-NEUTROPHIL CYTOPLASMIC AUTOANTIBODIES WITH HL-60 CELLS [J].
CHARLES, LA ;
FALK, RJ ;
JENNETTE, JC .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1989, 53 (02) :243-253
[2]  
CHRISTENSON VD, 1991, J RHEUMATOL, V18, P575
[3]   ANTILACTOFERRIN ANTIBODIES IN PATIENTS WITH RHEUMATOID-ARTHRITIS ARE ASSOCIATED WITH VASCULITIS [J].
COREMANS, IEM ;
HAGEN, EC ;
DAHA, MR ;
VANDERWOUDE, FJ ;
VANDERVOORT, EAM ;
KLEIJBURGVANDERKEUR, C ;
BREEDVELD, FC .
ARTHRITIS AND RHEUMATISM, 1992, 35 (12) :1466-1475
[4]  
DAVENPORT A, 1992, CLIN NEPHROL, V37, P124
[5]   RELATIONSHIP BETWEEN DISEASE-ACTIVITY AND ANTINEUTROPHIL CYTOPLASMIC ANTIBODY CONCENTRATION IN LONG-TERM MANAGEMENT OF SYSTEMIC VASCULITIS [J].
DEOLIVIERA, J ;
GASKIN, G ;
DASH, A ;
REES, AJ ;
PUSEY, CD .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1995, 25 (03) :380-389
[6]   VASCULITIS AND ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODIES ASSOCIATED WITH PROPYLTHIOURACIL THERAPY [J].
DOLMAN, KM ;
GANS, ROB ;
VERVAAT, TJ ;
ZEVENBERGEN, G ;
MAINGAY, D ;
NIKKELS, RE ;
DONKER, AJM ;
BORNE, AEGKV ;
GOLDSCHMEDING, R .
LANCET, 1993, 342 (8872) :651-652
[7]  
FABER V, 1967, ACTA MED SCAND, V179, P257
[8]   ANTI-NEUTROPHIL CYTOPLASMIC AUTOANTIBODIES WITH SPECIFICITY FOR MYELOPEROXIDASE IN PATIENTS WITH SYSTEMIC VASCULITIS AND IDIOPATHIC NECROTIZING AND CRESCENTIC GLOMERULONEPHRITIS [J].
FALK, RJ ;
JENNETTE, JC .
NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (25) :1651-1657
[9]  
FLESCH BK, 1991, AM J KIDNEY DIS, V18, pA201
[10]   ANTINEUTROPHIL CYTOPLASMIC ANTIBODY - A USEFUL SEROLOGICAL MARKER FOR VASCULITIS [J].
GOEKEN, JA .
JOURNAL OF CLINICAL IMMUNOLOGY, 1991, 11 (04) :161-174